Summary
Eighteen patients over 60 years old with a histologically proven diagnosis of glioblastoma multiforme were treated by a short radiotherapy course (3000 cGy midline dose by two opposed portals to the whole brain). Results in terms of survival and function appeared to be as good as with the standard course of six to seven weeks as reported in the literature.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Norell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 94:333–343, 1978
Chang CH, Schoenfeld D, Horton J, Salazar O, Perez Tamayo R, Kramer S: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of gliomas. Cancer 52:997–1007, 1983
Cooper JS, Borok TL, Ransohoff J, Carella RJ: Malignant glioma: Results of combined modality therapy. JAMA 248:62–65, 1982
Foo SH, Hiesiger E, Wise A, Ransohoff J, George A, Lin J, Newall J: Quality of long term survival of treated patients with malignant glioma. (Abstr) ASCO Proceedings 5:1236, 1986
Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30:907–911, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Newall, J., Ransohoff, J. & Kaplan, B. Glioblastoma in the older patient: how long a course of radiotherapy is necessary?. J Neuro-Oncol 6, 325–327 (1988). https://doi.org/10.1007/BF00177427
Issue Date:
DOI: https://doi.org/10.1007/BF00177427